Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 072573
Company: MYLAN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
PRAZOSIN HYDROCHLORIDE PRAZOSIN HYDROCHLORIDE EQ 1MG BASE CAPSULE; ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/28/1989 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/03/2002 SUPPL-8 Labeling

Label is not available on this site.

08/01/2000 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

02/25/1998 SUPPL-6 Manufacturing (CMC)

Label is not available on this site.

02/05/1998 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

10/15/1993 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

10/04/1990 SUPPL-2 Labeling

Label is not available on this site.

01/31/1990 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

PRAZOSIN HYDROCHLORIDE

CAPSULE; ORAL; EQ 1MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
PRAZOSIN HYDROCHLORIDE PRAZOSIN HYDROCHLORIDE EQ 1MG BASE CAPSULE; ORAL Prescription No AB 072573 MYLAN

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English